About the Company
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OTIC News
Otonomy, Inc. Common Stock (OTIC)
Nasdaq provides updated worldwide news headlines. Here you can find up-to-the-minute news and analysis of the company that you are researching for potential investment opportunities.
Syncona to acquire struggling AGTC for $23.5 million
The company has entered into strategic collaborations with Bionic Sight, Inc. – and innovator in optogenetics and retinal coding – and the biopharmaceutical company Otonomy, Inc., which ...
Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported financial results for the quarter ended June 30 ...
Inc. 5000 Conference
She spoke at the 2023 Inc. 5000 Conference about the difference between marketing and advertising. At the Inc. 5000 Conference, Howroyd, the first Black woman to build and own a billion-dollar ...
Netlist, Inc. (NLST)
Netlist, Inc. (PNK:NLST) Q1 2024 Earnings Call Transcript April 25, 2024 Netlist, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.05. NLST isn’t one of ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Hospital research team presented with award for disease clinical trial
The otonomy trial was originally carried out only ... To receive an award from INC Research is a great achievement. It has been awarded in recognition of the excellent conduct displayed by the ...
The Rise of China, Inc.
China, Inc.' enjoys the agility of a firm and the vast resources of a state. Meanwhile, foreign firms competing with Chinese firms can find themselves matched against the mighty Chinese state. The ...
Tanger Inc. Common Stock (SKT)
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...
Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals (NYSE:ATNM) closed the most recent trading day at $11.16, moving -1.06% from the previous trading session. This change lagged the S&P 500's daily loss ...
Apple Inc. (AAPL) Interactive Stock Chart - Yahoo Finance
With the peak of first quarter earnings season in the rearview, stocks got back to their winning ways last week ahead of a slower calendar for corporate and economic news. Google has a lot at stake as ...
Loading the latest forecasts...